Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. - Wikidata - awgldk - TriplyDB

Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial.

Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial.

http://www.wikidata.org/entity/Q36015736

about

Interventions for preventing falls in older people living in the community Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences Pharmacological perspectives in sarcopenia: a potential role for renin-angiotensin system blockers?Muscle function in COPD: a complex interplay The renin-angiotensin system and prevention of age-related functional decline: where are we now?Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II).Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.Are we closer to having drugs to treat muscle wasting disease?Optimizing the benefits of exercise on physical function in older adults.The implication of frailty on preoperative risk assessment Frailty in elderly people Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review.Managing sarcopenia and its related-fractures to improve quality of life in geriatric populations.Optimal management of sarcopenia.Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update.Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies.Perioperative frailty A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.Role of frailty assessment in patients undergoing cardiac interventions Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?Determinants of frailty: the added value of assessing medication One size may not fit all: anti-aging therapies and sarcopenia Effect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects: A Systematic Review and Meta-Analysis.Novel intriguing strategies attenuating to sarcopenia Multi-modal intervention to reduce cardiovascular risk among hypertensive older adults: Design of a randomized clinical trial.Disability and incident coronary heart disease in older community-dwelling adults: the Three-City Study.Angiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: the Health, Aging and Body Composition study.Medication use and functional status decline in older adults: a narrative review.Interaction between bone and muscle in older persons with mobility limitations Successful aging: Advancing the science of physical independence in older adults.FRAILTY: A Report from the 3(rd) Joint Workshop of IAGG/WHO/SFGG, Athens, January 2012 Statins, angiotensin-converting enzyme inhibitors, and physical performance in older women.Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study.Angiotensin-II blockage, muscle strength, and exercise capacity in physically independent older adults.Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise.Effect of spironolactone on physical performance in older people with self-reported physical disability.Antihypertensive Use and the Effect of a Physical Activity Intervention in the Prevention of Major Mobility Disability Among Older Adults: The LIFE Study.The effects of antihypertensive medications on physical function.Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration.

P2860

Q24241432-703D97EB-B6F4-472C-88A5-31D7D3DDAB30 Q26767412-407E594E-3362-467E-B361-551251E582CA Q26775758-1A6E2ABE-57D8-4B85-B71D-C558FA8563D8 Q26865732-02DD75A5-BCC7-4418-9709-C6B341C6066E Q28085528-AAEF5207-FAAC-4ED7-BB4E-ECAA6D4B3D4E Q31132903-6E8D578A-F198-45F7-8614-61C534DD3D5A Q33615993-0144D26B-7C97-4914-AB8D-A227E6A59135 Q33636677-A0894446-6254-4AA7-97D0-5D28651C8D52 Q33741103-16314A51-EBE9-497F-8526-575E9C50882D Q33779905-CCEFC15B-EC3E-41E4-8F6B-5738D269A5BC Q33825857-F26E82CC-E40C-486A-82CA-BFC096B9292B Q33902569-585B41D1-2A7E-4D70-80E9-D7A3077B78F0 Q33956866-DA16D82C-79CD-4D8C-90A2-7E0EA65DB27D Q33962042-880D41DA-C9B6-47E2-AFE2-DA78A249E90D Q34121822-96D892AD-4A4E-429D-B7E6-E49032BC6BCB Q34121836-8714C17F-F1D9-481F-A82C-55FE67B72A4B Q34157292-2B74F0F9-BDDB-458D-A648-C33D864A5075 Q34278764-33490135-CC76-46A1-A557-4ED3754E7080 Q34299825-0569AC5C-8109-4A36-A869-77BF54E3678E Q34333218-1AAC814C-EEDD-4E4B-89F7-54E7CB284F6E Q34886182-B237FA60-6A0F-4800-9DD6-611D4C5FF35A Q35506930-262507AA-56C1-446A-81AE-FDE62A46142F Q35740777-6C6E57CC-2A6D-42D4-863C-1320ACFE74D0 Q35749354-4DC64B1E-F4A4-43A8-B0B7-384C16BFE7E5 Q35829811-292DF4E4-EF95-44F8-8838-E681AC8FB0EE Q35908858-87D7BDEA-9CA3-4B80-890F-6120F1025B6F Q36015682-B6BC6CD2-75C9-421F-A8B7-CB067D03A662 Q36076367-F0A5AB86-79C3-4A2C-BA33-AF97148D56AA Q36099587-B72A6F14-D654-4129-8423-399AE69B9356 Q36100758-1AB97F47-BE8D-43AE-84B4-C0CB5CF65939 Q36322590-63291086-E05F-458E-8F29-7AA9589AFD4A Q36450567-2199B722-21B9-4AAF-80ED-CA9AB3F984C0 Q36463353-1C1238EA-BF9A-4C1D-870C-5D19D1B226B0 Q36537163-BB0D630A-1D89-40FC-ADF3-AF7940EF501C Q36690359-FC23AED4-B2FD-427C-BB0E-7DCC383C44AD Q36764607-73862D4D-E4E2-434A-A387-6773B704EB69 Q36963464-BC9E8E85-F89F-4C6C-B74C-86D420E2A728 Q37000459-8647EA03-6971-48AF-B4B6-A1108B983287 Q37056799-D8BEE856-1A6D-4F96-84E9-8AC19B83C582 Q37099711-8841DA0A-744B-4CD3-85D3-F3DB7C285DFE

P2860

Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial.

http://www.wikidata.org/entity/Q36015736

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Effect of perindopril on physi ...... a randomized controlled trial.

@ast

Effect of perindopril on physi ...... a randomized controlled trial.

@en

type

label

Effect of perindopril on physi ...... a randomized controlled trial.

@ast

Effect of perindopril on physi ...... a randomized controlled trial.

@en

prefLabel

Effect of perindopril on physi ...... a randomized controlled trial.

@ast

Effect of perindopril on physi ...... a randomized controlled trial.

@en

P1433

Q36015736-4D42E8F2-71C4-483A-83D8-A0E7D9D49505

P1476

Q36015736-8561A2AD-CA66-4626-9029-472B88EAA226

P2093

Q36015736-43178A45-B427-4767-B919-A339D48C2608

Q36015736-527691C5-B494-4B63-80DE-A3C8A7627DE3

Q36015736-5B9DE0FA-2A6F-466C-8480-B914C2504797

Q36015736-793ED05A-8A59-484E-B0B9-B716B955C21E

P2860

Q36015736-02F54F95-66A8-42DE-939F-1BCC2503B9BF

Q36015736-0A9E242D-53D2-451A-8780-657168B7EF02

Q36015736-184AD3A3-A2A8-46E7-832E-1CFAE4D1A425

Q36015736-1E4BB811-0B2A-459C-8A65-73E7450EC896

Q36015736-245C4F84-2525-4391-92FE-849267DAEBD4

Q36015736-2F8801C1-8AC1-4CB2-8DE5-DDA3D1CB4263

Q36015736-4BD232E9-EE3D-4BD2-9EFC-1D13C6AC3B37

Q36015736-5A40AF4C-2D58-48DE-85B7-3EFE18FCEEDF

Q36015736-67ACE521-0C12-422A-AB54-AB30EFC04FD9

Q36015736-78062F06-689E-4397-9EB5-FA613FB02510

P304

Q36015736-D4460780-FA2E-4579-966F-00AD911629CC

P31

Q36015736-F514F063-D7B9-49FD-81E4-769EFCC06288

P356

Q36015736-A2F6D5AB-EC37-44B2-B11B-58D662E31568

P407

Q36015736-24096E6D-D7C5-4D55-AEB5-3D9FB4B688EE

P433

Q36015736-4DA6A111-EA64-4481-A67D-3CBB85F109CB

P478

Q36015736-62DFA8EA-5C26-461A-A41F-764CFF3BD345

P577

Q36015736-CA6D79D5-FA67-4E62-B3DF-50D7F32CB589

P5875

Q36015736-8C8F5475-533F-42C0-AC8C-FCDD7BBE9927

P698

Q36015736-DBE7BEBC-73E7-4E86-BC11-79E5E21FF75B

P932

Q36015736-8E249A1A-C14B-4756-A581-A8C45EA50B1D

P356

P1433

Canadian Medical Association Journal

P1476

Effect of perindopril on physi ...... a randomized controlled trial.

@en

P2093

Allan D Struthers

http://www.w3.org/2001/XMLSchema#string

Deepa Sumukadas

http://www.w3.org/2001/XMLSchema#string

Marion E T McMurdo

http://www.w3.org/2001/XMLSchema#string

Miles D Witham

http://www.w3.org/2001/XMLSchema#string

P2860

The timed "Up & Go": a test of basic functional mobility for frail elderly persons

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test.

EQ-5D: a measure of health status from the EuroQol Group.

Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide

Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition.

Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods.

Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients

The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.

Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial.

P304

867-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.061339

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5920706

http://www.w3.org/2001/XMLSchema#string

P698

17923654

http://www.w3.org/2001/XMLSchema#string

P932

1995143

http://www.w3.org/2001/XMLSchema#string